Lundbeck has stopped development of a subcutaneous formulation of its migraine drug Lu AG09222 as the Danish drugmaker ...

Virginia Tech's study on battery interfaces offers critical insights for developing high-energy, stable batteries essential ...

AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement for orally delivered small molecule drugs, today announced the introduction of the ...

A new approach to drug formulation may enable the self-administration of drugs that last up to 2 years.

Shilpa Medicare's stock rose 4.73% to Rs 678.85 after the company announced that its marketing partner, Amneal Pharmaceuticals, has launched BORUZU injections.

The formulation allows for greater stockpiling, with Bavarian Nordic already working with the US government to add to vaccine ...

The Good Bug aims to achieve Rs 1,000 crore in revenues by FY28, driven by its obesity solutions products, including a patent ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced fourth quarter financial results ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, ...

RediClinic’s Shilajit supplement is rapidly gaining popularity as a superfood for men’s health due to its powerful blend of natural minerals, fulvic acid, and bioactive compounds that enhance energy, ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...

According to Theratechnologies, Egrifta WR is set to replace Egrifta SV. The Food and Drug Administration (FDA) has approved Egrifta WR ™, a new concentrated formulation (F8) of tesamorelin, for the ...